Results 71 to 80 of about 3,132 (216)
One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
, 2023 Ryan B Rush1– 3 1Department of Ophthalmology, Panhandle Eye Group, Amarillo, TX, USA; 2Department of Ophthalmology, Southwest Retina Specialists, Amarillo, TX, USA; 3Department of Surgery, Texas Tech University Health Science Center, Amarillo, TX ...Rush RBcore Real world outcomes of faricimab in treatment resistant neovascular age-related macular degeneration among Asian patients
Scientific ReportsTo describe the real-world efficacy and safety outcome measurements of faricimab use in treatment-resistant neovascular age-related macular degeneration (nAMD) in a cohort of Asian patients.Elvine Zhong Oen Neo, Kevin Wei Onn Liang, Zhi Hong Toh, Andrew Bee Yong Tan, Darren Mun Yoong Choy, Wenting Zhou, Helen Fang Mi, Louis Wei Yi Lim, Yu Qiang Soh, Jacob Yu Hang Chin, Zheng Xian Thng, Karen Jhi Wen Chia, Augustinus Laude, Colin Siang Hui Tan, Tock Han Lim, Nicola Yi’an Gan, Rajesh Rajagopalan, Wei Kiong Ngo +17 moredoaj +1 more sourceCausal Association Between Commonly Used Medicines and Diabetes‐Related Eye Diseases: Univariable and Multivariable Mendelian Randomization Study
Journal of Diabetes Research, Volume 2026, Issue 1, 2026.Background
Diabetic patients require long‐term polypharmacy, yet the causal effects of these medications on ocular complications—specifically diabetic retinopathy (DR), diabetic maculopathy (DMac), and glaucoma—remain unclear due to confounding in observational studies.Yu Wang, Chak Kwong Cheng, Lamusi A., Mingyue Jin, Chang Wang, Riccardo Calafiore +5 morewiley +1 more sourceFaricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison
Drug Target InsightsObjectives: To assess through an indirect treatment comparison (ITC) the potential benefit of faricimab over the anti-vascular endothelial growth factor (VEGF) real-life scenario, hereby defined standard of care (SoC), in Italy, that is, aflibercept ...Carlotta Galeone, Federica Turati, Massimo Nicolò, Mariacristina Parravano, Stela Vujosevic, Laura Bianchino, Emilia Sicari, Paolo Lanzetta +7 moredoaj +1 more sourceRecent Investigations on Pathogenesis, Biomarkers, Epigenetics, and Emerging Therapeutic Strategies to Modulate Multiple Signaling Pathways in Diabetic Retinopathy
Journal of Ophthalmology, Volume 2026, Issue 1, 2026.Background
Diabetic retinopathy (DR) is a progressive microvascular complication related to diabetes mellitus and remains a profound cause of vision impairment and blindness globally. In addition to its ocular manifestations, DR is increasingly recognized as a main risk factor for systemic diseases, including cardiovascular and neurodegenerative ...Zixuan Huang, Jing Wei, Dayong Yang, Kofi Asiedu +3 morewiley +1 more sourceHuman Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe [PDF]
Mark R Barakat,1,2 Henry M Kwong Jr,2,3 Gelson Marcon,4 Olivia E O’Leary,4 Liliana P Paris,5 Petrick Schneider,4 Yannan Tang,5 Jordan M Graff2,6,7 1Retina Macula Institute of Arizona, Scottsdale, AZ, USA; 2Department of Ophthalmology, University of ...Graff JM, O'Leary OE, Paris LP, Barakat MR, Schneider P, Kwong Jr HM, Marcon G, Tang Y +7 morecore Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
The Lancet, 2022 J. Heier, A. Khanani, Carlos Quezada Ruiz, K. Basu, P. Ferrone, C. Brittain, M. Figueroa, Hugh Lin, F. Holz, V. Patel, T. Lai, David Silverman, C. Regillo, Balakumar Swaminathan, F. Viola, C. Cheung, T. Wong, A. Abbey, E.B.K Abdulaeva, P. Abraham, A. A. Civera, H. Agostini, A. Alezzandrini, V. Alfaro, A. Almony, L. Altay, Payam Amini, Andrew N. Antoszyk, Etelka Aradi, L. Arias, J. Arnold, R. Asaria, S. Astakhov, Y. Astakhov, C. Awh, Chandrakumar Balaratnasingam, Sanjiv Banerjee, C. Baumal, M. Becker, Rubens N. Belfort, Galina Bratko, William Bridges, Jamin S. Brown, David M. Brown, M. Budzinskaya, S. Buffet, S. Burgess, I. Byon, C. Cagini, J. Calzada, S. Cameron, P. Campochiaro, John Carlson, Â. Carneiro, C. Chan, E. Chang, Andrew Chang, D. Chao, N. Chaudhry, C. Chee, A. Cheek, S. Chen, San-Ni Chen, G. Cheung, Saradha Chexal, M. Chittum, David Chow, A. Cole, B. Connolly, P. Cornut, Steven C. Couvillion, Carl J. Danzig, Vesselin Daskalov, A. Dessouki, F. Devin, Michael L Dollin, R. Dolz, L. Downey, R. Dreyer, P. Dugel, David A. Eichenbaum, B. Eldem, R. Engstrom, J. Escobar, N. Eter, D. Faber, N. Falk, L. Feiner, Alvaro Fernandez Vega, P. Ferrone, Marta Figueroa, Howard I. Fine, Mitchell Fineman, G. M. Fox, C. Français, Pablo Franco, S. Fraser-bell, Nicholas Fung, F. Sola, R. Gale, A. García-Layana, J. Gasperini, Maciej Gawęcki, F. Ghanchi, M. Gill, M. Giunta, D. Glaser, Michael B. Goldstein, Francisco Gomez Ulla, Fumi Gomi, Víctor González, J. Graff, Sunil Gupta, R. Guthoff, R. Guymer, A. Haas, Robert Hampton, Katja Hatz, Ken Hayashi, J. Heier, E. Herba, Vrinda S. Hershberger, Patrick Higgins, N. Holekamp, S. Honda, James Howard, Allen Hu, Stephen M Huddleston, T. Iida, H. Imaizumi, Yasuo Ito, Y. Ito, S. Itty, G. Javey, Cameron G. Javid, T. Kaga, J. Kałużny, S. Kang, K. Kapoor, L. Karabas, Tsutomu Kawasaki, Patrick J. Kelty, Á. Kerényi, A. Khanani, R. Khoramnia, R. Khurana, Kazuhiro Kimura, Kendra Klein-Mascia, Namie Kobayashi, L. Kodjikian, H. Koizumi, G. Kokame, A. Kulikov, Henry Kwong, R. Kwun, T. Lai, Chi-Chun Lai, L. Lalonde, P. Lanzetta, M. Larsen, A. Lavina, W. Lee, Ji Eun Lee, Seong-Cheol Lee, J. Levy, Luke B Lindsell, Mimin Liu, N. London, A. Lotery, D. L. Rechy, A. Luckie, D. Maberley, T. Maeno, S. Mahmood, Fuad Makkouk, D. Marcus, A. Margherio, H. Massé, Hisashi Matsubara, R. Maturi, S. Mehta, G. Menon, Jale Menteş, M. Michels, Y. Mitamura, Paul Mitchell, Q. Mohamed, J. Monés, Rodrigo Montemayor Lobo, J. Montero, Jeffrey T. Moore, R. Mori, Haia Morori-Katz, R. Mukherjee, T. Murata, M. Muzyka-Woźniak, M. Nardi, N. Narendran, M. Nicolò, J. Nielsen, T. Nishimura, K. Noda, A. Nowinska, H. Oh, Matthew P. Ohr, A. Okada, P. Oleksy, S. Ono, S. Ozdek, B. Ozturk, L. Pablo, K. Park, D. Parke, M. Parravano, P. Patel, Apurva Patel, Sunil S. Patel, Sugat S Patel, D. Pauleikhoff, I. Pearce, J. Pearlman, I. Petkova, D. Pieramici, N. Pozdeyeva, J. Qureshi, D. Raczyńska, J. Estudillo, R. Rathod, H. Razavi, Gayatri S. Reilly, F. Ricci, R. Rich, B. Romanowska-Dixon, I. Rosenblatt, J. Moreno, S. Sacu, H. Saedon, Usman Saeed, M. Sagong, T. Sakamoto, S. Sandhu, L. Sararols, M. Saravia, Ramin Schadlu, P. Schlottmann, T. Sekiryu, A. Seres, F. Şermet, Sumit P. Shah, Rohan Shah, Ankur Shah, T. Sheidow, V. Sheth, C. Shiragami, B. Sikorski, Rufino Silva, L. Singerman, R. Sisk, T. Sørensen, E. Souied, D. Spinak, G. Staurenghi, R. Steinmetz, G. Stoller, R. Stoltz, Eric P Suan, I. Suñer, Y. Suzanne, R. Tadayoni, Kanji Takahashi, K. Takayama, A. Taleb, J. Talks, H. Terasaki, J. Thompson, E. Tóth-Molnár, Khoi D. Tran, R. Tuli, E. Uchiyama, A. Vajas, Janneke Van Lith-Verhoeven, B. Varsányi, G. Virgili, G. Vogt, M. Völker, David J. Warrow, Pamela Weber, J. A. Wells, S. Wickremasinghe, M. Wieland, G. Williams, Thomas Williams, D. Wong, King Wong, James Wong, Ian Y. H. Wong, Robert Wong, B. Wowra, C. Wykoff, Ayana Yamashita, K. Yasuda, G. Yılmaz, Glenn Yiu, Ai Yoneda, Y. Yoon, Barak Yoreh, HyeongGon Yu, Seung-Young Yu, Tatiana S. Yurieva, A. Zambrano, B. Zatorska, Carlos Zeolite +311 moresemanticscholar +1 more sourceFaricimab for treatment-resistant choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD): seven-months results using artificial intelligence and OCTA
International Journal of Retina and VitreousTo analyze the therapeutic response to faricimab 6 mg/0.05 ml in eyes with neovascular AMD (nAMD) with refractory intra- and/or subretinal fluid due to choroidal neovascularization (CNV), previously unresponsive to 4 mg monthly aflibercept and ...A. Heinke, Alexandra Warter, Ines D. Nagel, A. Agnihotri, N. Mehta, C. Galang, Daniel N. Deussen, Dirk-Uwe G. Bartsch, Lingyun Cheng, Henry Ferreyra, William R. Freeman +10 moresemanticscholar +1 more source
